Results 261 to 270 of about 664,100 (294)

Enhancing diagnostic precision: a multicentric study of endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy in lymphoproliferative disorders. [PDF]

open access: yesERJ Open Res
Ariza-Prota M   +16 more
europepmc   +1 more source

Malignancy in Adults with Inborn Errors of Immunity: A Retrospective Single-Center Study. [PDF]

open access: yesJ Clin Immunol
Gumusburun R   +21 more
europepmc   +1 more source

Treatment outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg-type in the rituximab era

open access: yesBlood Cancer Journal
Giulio Cassanello   +18 more
doaj   +1 more source

Trends in the incidence of cancers related to HIV-AIDS in Harare, Zimbabwe 1990-2019. [PDF]

open access: yesJ Natl Cancer Inst
Chokunonga E   +8 more
europepmc   +1 more source

Lymphomas

Update on Cancer Therapeutics, 2003
Hodgkin's and non-Hodgkin's lymphomas are an important part of the differential diagnosis of head and neck tumors. Their diagnosis begins with a complete history and physical examination and is confirmed with an appropriately obtained and prepared pathologic specimen.
Armando, Santoro   +2 more
openaire   +5 more sources

Lymphoma

Insight - the Journal of the American Society of Ophthalmic Registered Nurses, 1997
Lymphomas are rare tumors, which can be unilateral or bilateral. Lymphomas may affect the conjunctiva, the eyelid, and the orbit; and they may be diagnosed systemically. Ophthalmic nurses are the perfect health care professionals to educate and provide the care for these patients. An interesting patient who was diagnosed with a lymphoma is presented.
C A, Servodidio, D H, Abramson
openaire   +4 more sources

Lymphoma

Primary Care: Clinics in Office Practice, 2016
Lymphomas may be broadly divided into non-Hodgkin (90%) and Hodgkin (10%) types. Most lymphomas (90%) are of B cell origin but can also be T cell or natural killer cell. Clinical management of indolent and aggressive lymphomas is different. Aggressive lymphomas are more dangerous if left untreated yet a higher cell proliferation rate also renders them ...
Emiliano N, Mugnaini, Nilanjan, Ghosh
openaire   +2 more sources

HIV Lymphoma and Burkitts Lymphoma

The Cancer Journal, 2020
AbstractDespite widely available antiretroviral therapy, lymphoma remains the leading cause of death for human immunodeficiency virus (HIV)–infected persons in economically developed countries. Even a few months of drug interruptions can lead to drops in the CD4 cell count, HIV viremia, and an increased risk of lymphoma.
openaire   +3 more sources

Home - About - Disclaimer - Privacy